Maximizing Patent & Regulatory Exclusivities Available to Pharmaceutical & Biologic Products

Tuesday, April 03, 2012 (7:30 AM - 12:00 PM)

Obtaining and preserving commercial exclusivity for pharmaceutical and biologic products is critical to earning a return on the enormous research, development, and commercialization costs required to bring such products to market.  However, maximizing the commercial exclusivity achieved by a given product requires careful consideration of the both the patent and regulatory exclusivities available. 

Join us to learn about the complex system of patent and regulatory exclusivities applicable to pharmaceutical and biopharmaceutical products in the U.S. and internationally. Continental breakfast and light snacks provided. 

Sally Mannion, Chartered Patent Attorney, Cleveland IP, London, England
Maximizing Patent & Regulatory Protection for Therapeutic Products in Europe

Leonor Galvao de Botton, PhD, Registered Brazilian Patent and Trademark Agent, Di Blai, Parente & Associados, Brazil
Emerging Market Spotlight, Brazil

Samuel E. Webb, Partner, Stoel Rives, LLP, Seattle
Patent & Regulatory Exclusivities Available to Therapeutic and Medical Device Products in the U.S.

7:30 AM - 12:00 Noon
Registration and Continental Breakfast:  7:30AM - 8:00 AM
Program and Panel Presentations 8:00-12:00 PM

One Union Square
Union Square Boardroom (street level; behind the escalators)
600 University Street
Seattle, WA 98101

Registration Fees:
WBBA Member- $50.00
Non-Member- $75.00
Academia, Nonprofit, Student- $35.00

Thank you to our sponsors:


© 2012 Washington Biotechnology & Biomedical Association

Powered by